Evidence map›Paper›PMID 37916984›Full record

ArticleAging2023

Hepatoprotective effect of syringin combined with costunolide against LPS-induced acute liver injury in L-02 cells via Rac1/AKT/NF-κB signaling pathway.

Jingxin Mao, Lihong Tan, Cheng Tian, Wenxiang Wang, Hao Zhang, Zhaojing Zhu, Yan Li

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jingxin MaoChongqing Medical and Pharmaceutical College, Chongqing 400030, China.
Lihong TanChongqing Medical and Pharmaceutical College, Chongqing 400030, China.
Cheng TianChongqing Medical and Pharmaceutical College, Chongqing 400030, China.
Wenxiang WangChongqing Three Gorges Medical College, Chongqing 404120, China.
Hao ZhangChongqing Medical and Pharmaceutical College, Chongqing 400030, China.
Zhaojing ZhuChongqing Medical and Pharmaceutical College, Chongqing 400030, China.
Yan LiChongqing Medical and Pharmaceutical College, Chongqing 400030, China.
Chongqing Medical and Pharmaceutical College · CNChongqing Three Gorges University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute liver injury (ALI) leads to abnormal liver function and damage to liver cells. Syringin (syr) and costunolide (cos) are the major extracts from

Indexed as

NF-kappa BProto-Oncogene Proteins c-aktGlucosidesLactonesLipopolysaccharidesLiverPhenylpropionatesSesquiterpenesSignal TransductioncostunolideGlucosidesLactonesLipopolysaccharidesNF-kappa BPhenylpropionatesProto-Oncogene Proteins c-aktSesquiterpenessyringinacute liver injurycostunolideDolomiaea souliei (Franch.) C.Shihhepatoprotective effectsyringin

Identifiers

PMID37916984
PMCPMC10683587
OpenAlexW4388124950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.